Capnography Devices Market Regional Analysis

Capnography Devices Market size was valued at USD 688.45 Million in 2023 and is poised to grow from USD 756.61 Million in 2024 to USD 1610.1 Million by 2032, growing at a CAGR of 9.9% during the forecast period (2025-2032).

Medtronic, Philips Healthcare, and Respironics are dominating the competitive capnography devices industry. Through the production of advanced capnography solutions having more accuracy, mobility, and integration with other monitoring systems, innovation is the main concern of these businesses. Other smaller businesses, and new players, are adding to competition by developing portable and relatively affordable devices. In this industry, firms often enter strategic alliances, mergers, and acquisitions to expand their share of the market and enhance their product offerings.  'Medtronic plc (Ireland)', 'Philips Healthcare (Netherlands)', 'Masimo Corporation (US)', 'Smiths Medical (US)', 'Drägerwerk AG & Co. KGaA (Germany)', 'Nihon Kohden Corporation (Japan)', 'Welch Allyn, Inc. (US)', 'Nonin Medical, Inc. (US)', 'CareFusion Corporation (US)', 'ZOLL Medical Corporation (US)', 'Schiller AG (Switzerland)', 'Edan Instruments, Inc. (China)', 'Infinium Medical (US)', 'Schmitz u. Söhne GmbH & Co. KG (Germany)', 'HEYER Medical AG (Germany)', 'BPL Medical Technologies (India)', 'DiaSys Diagnostic Systems GmbH (Germany)', 'CONTEC Medical Systems Co., Ltd. (China)', 'Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)', 'Vyaire Medical (US)'

The main driving force behind the growth of the market is the increasing prevalence of respiratory disorders such as asthma, sleep apnea, and COPD. Since these conditions require continuous monitoring of the carbon dioxide (CO2) levels, capnography devices play a significant role in the proper management and diagnosis of respiratory disorders, especially in critical care, emergency care settings, and ambulatory care settings. 

Ambulatory Care Growth: Shorter hospital stays, cost-effectiveness, and faster periods of recovery are driving the market for the use of capnography devices, meeting the rising need for ambulatory care services. These devices ensure respiratory monitoring in minimally invasive procedures and outpatient settings with real-time CO2 monitoring, critical for patient safety at all stages of anesthesia and recovery. 

In 2023, the North American capnography devices market dominated the market. The primary driver in the regional market is the rising number of respiratory conditions caused by unhealthy lifestyles and higher stress levels. Further demand for products will also be led by new reimbursement models in the area for respiratory and monitoring solutions, along with strict regulations geared toward clinical effectiveness, patient safety, and medical efficacy. According to a 2020 American Psychological Association poll, 49% of American people said that their conduct was negatively influenced by increasing stress, and 21% reported that their physiological tension worsened as a result.